ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K105. A total of 13 filers reported holding ACASTI PHARMA INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $1,000 | – | 1,490 | 0.0% | 0.00% | – |
Q2 2015 | $0 | -100.0% | 1,490 | 0.0% | 0.00% | – |
Q1 2015 | $1,000 | 0.0% | 1,490 | 0.0% | 0.00% | – |
Q4 2014 | $1,000 | 0.0% | 1,490 | 0.0% | 0.00% | – |
Q3 2014 | $1,000 | -50.0% | 1,490 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $2,000 | 0.0% | 1,490 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $2,000 | 0.0% | 1,490 | +5.4% | 0.00% | 0.0% |
Q4 2013 | $2,000 | – | 1,413 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 4,731,200 | $1,252,000 | 0.05% |
INTACT INVESTMENT MANAGEMENT INC. | 1,347,800 | $452,000 | 0.02% |
Fiera Capital Corp | 621,542 | $1,554,000 | 0.01% |
Alpine Global Management, LLC | 10,000 | $3,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 18,131 | $4,000 | 0.00% |
Citadel Advisors | 36,095 | $10,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 447,023 | $120,000 | 0.00% |
1832 Asset Management L.P. | 272,812 | $69,000 | 0.00% |
Renaissance Technologies | 64,100 | $17,000 | 0.00% |
ROYAL BANK OF CANADA | 5,000 | $1,000 | 0.00% |